- Company Overview for ENDOPURE MEDICAL LIMITED (05902779)
- Filing history for ENDOPURE MEDICAL LIMITED (05902779)
- People for ENDOPURE MEDICAL LIMITED (05902779)
- Insolvency for ENDOPURE MEDICAL LIMITED (05902779)
- Registers for ENDOPURE MEDICAL LIMITED (05902779)
- More for ENDOPURE MEDICAL LIMITED (05902779)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
27 Sep 2024 | AA | Total exemption full accounts made up to 31 December 2023 | |
19 Sep 2024 | CS01 | Confirmation statement made on 5 August 2024 with no updates | |
27 Sep 2023 | AA | Total exemption full accounts made up to 31 December 2022 | |
16 Aug 2023 | CS01 | Confirmation statement made on 5 August 2023 with no updates | |
24 Apr 2023 | AD02 | Register inspection address has been changed from Shoulder Way House Tidmington Shipston-on-Stour Warwickshire CV36 5LP England to 5th Floor Halo Counterslip Bristol BS1 6AJ | |
20 Apr 2023 | AD03 | Register(s) moved to registered inspection location Shoulder Way House Tidmington Shipston-on-Stour Warwickshire CV36 5LP | |
25 Nov 2022 | CERTNM |
Company name changed transdermal technology & systems (tts) LIMITED\certificate issued on 25/11/22
|
|
18 Nov 2022 | TM02 | Termination of appointment of Mark Rupert Tucker as a secretary on 11 November 2022 | |
18 Nov 2022 | TM01 | Termination of appointment of Mark Rupert Tucker as a director on 11 November 2022 | |
18 Nov 2022 | AP01 | Appointment of Wilson Cecil Blaney as a director on 17 November 2022 | |
29 Sep 2022 | CS01 | Confirmation statement made on 5 August 2022 with no updates | |
25 Aug 2022 | AA | Total exemption full accounts made up to 31 December 2021 | |
24 Sep 2021 | AA | Total exemption full accounts made up to 31 December 2020 | |
17 Sep 2021 | CS01 | Confirmation statement made on 5 August 2021 with no updates | |
12 Feb 2021 | AP01 | Appointment of Mr Paul Richard Atherton as a director on 1 February 2021 | |
12 Feb 2021 | TM01 | Termination of appointment of Samuel Redcliffe Sneddon as a director on 31 January 2021 | |
14 Dec 2020 | PSC09 | Withdrawal of a person with significant control statement on 14 December 2020 | |
25 Nov 2020 | AA | Total exemption full accounts made up to 31 December 2019 | |
11 Sep 2020 | CS01 | Confirmation statement made on 5 August 2020 with updates | |
16 Sep 2019 | CS01 | Confirmation statement made on 5 August 2019 with no updates | |
09 May 2019 | AA | Total exemption full accounts made up to 31 December 2018 | |
28 Sep 2018 | AA | Total exemption full accounts made up to 31 December 2017 | |
16 Aug 2018 | CS01 | Confirmation statement made on 5 August 2018 with no updates | |
23 Oct 2017 | AA | Micro company accounts made up to 31 December 2016 | |
11 Sep 2017 | PSC02 | Notification of Tts Pharma Ltd as a person with significant control on 6 April 2016 |